Fractyl Health, Inc. (GUTS)
Fractyl Health develops and sells medical devices, including its Revita device, from Burlington, Massachusetts. It last closed at $0.97 on Nov 17, down 2.66% on the day. The average 12-month price target from 3 analysts is $22.67 (+2247.9% from the last close), with a high of $40.00 and a low of $4.00. Analyst consensus is Buy, based on the latest ratings from 3 firms (2 buy, 1 hold, 0 sell).
Key Stats
Fiscal 2025Not reported for this period.
From GUTS's SEC filings, latest 10-Q for the period ending Dec 31, 2025 (filed Nov 12).
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 3 analysts who set a price target on GUTS in the past 90 days. The average target is $22.67, with a high of $40.00 and a low of $4.00, compared with the last close of $0.97.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 13 | Canaccord Genuity | Target raised | Buy | $39 → $40 |
| Nov 13 | HC Wainwright & Co. | Target raised | Buy | $8 → $24 |
| Oct 20 | Canaccord Genuity | Maintained | Buy | $39 |
| Oct 19 | Morgan Stanley | Maintained | Hold | $4 |
| Jul 1 | Craig-Hallum | Initiated | Buy | $4 |
Technical Analysis
The stock sits between its 20 and 50 day averages. It is 601% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the 20 day average at $0.95, and the nearest resistance the Pivot at $0.97.
| RSI (14) | 26.11 | Oversold below 30 | Oversold |
| MACD | -0.73 | Above its signal line | Bullish |
| Stochastic | 55.8 | Middle of its range | Neutral |
| ADX (14) | 58.0 | Strong downtrend | |
| Williams %R | -40.9 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 6.0 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +7.5% | Change over 10 sessions | Bullish |
| ATR (14) | $0.22 | Typical daily range, 23.2% of price |
| RSI (14) | 25.58 | Oversold below 30 | Oversold |
| MACD | -2.43 | Below its signal line | Bearish |
| Stochastic | 1.4 | Near the bottom of its range | Oversold |
| ADX (14) | 23.9 | Weak trend | |
| Williams %R | -98.2 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -110.0 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −87.4% | Change over 10 sessions | Bearish |
| ATR (14) | $1.36 | Typical daily range, 141.1% of price |
What happened before
See how GUTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90DNo whale options trades in GUTS in the last 90 days.
GUTS Institutional Ownership
Full report →- ▲38 buying vs 32 selling
- ▼Shares held by funds -23.7%
- ▼Funds holding -4
- ▲Superinvestors: 3 added, 0 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 74 | 78 | −5.1% |
| In funds' top 10 | 2 | 3 | −33.3% |
| Held by funds | – | – | – |
| New / increased | 20 / 18 | 12 / 17 | +31.0% |
| Reduced / sold out | 10 / 22 | 15 / 18 | −3.0% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GUTS is in one of them and how their past GUTS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GUTS in an article yet. Here's the latest on the wider market.
About Fractyl Health
Fractyl Health is a medical device company based in Burlington, Massachusetts. It develops medical devices, including its Revita device, which carries a CE mark and is sold in the European Union and the European Economic Area. The company is also developing product candidates that must receive approval or certification from regulators such as the FDA and European notified bodies before they can be sold. Its products are subject to medical device rules in the EU and the United Kingdom.
- Headquarters
- Burlington, MA
- Founded
- 2010
- Website
- fractyl.com ↗


